✦ LIBER ✦
674 Topoisomerase II alpha (TOP2A) alterations as a predictive marker for epirubicin sensitivity in 805 high-risk breast cancer patients. A randomised DBCG trial (DBCG89D)
✍ Scribed by A. Knoop; H. Knudsen; E. Balslev; B. Rasmussen; J. Overgaard; K. Nielsen; A. Schønau; K. Gunnarsdóttir; H. Mouridsen; B. Ejlertsen
- Book ID
- 118620846
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 311 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.